These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 24041710

  • 1. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.
    De Smet R, Demoor T, Verschuere S, Dullaers M, Ostroff GR, Leclercq G, Allais L, Pilette C, Dierendonck M, De Geest BG, Cuvelier CA.
    J Control Release; 2013 Dec 28; 172(3):671-8. PubMed ID: 24041710
    [Abstract] [Full Text] [Related]

  • 2. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.
    Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM.
    mBio; 2010 Jul 20; 1(3):. PubMed ID: 20802824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simultaneous induction of antigen-specific IgA helper T cells and IgG suppressor T cells in the murine Peyer's patch after protein feeding.
    Richman LK, Graeff AS, Yarchoan R, Strober W.
    J Immunol; 1981 Jun 20; 126(6):2079-83. PubMed ID: 6164719
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.
    Franco L, Benedetti R, Ferek GA, Massouh E, Fló J.
    Cell Immunol; 1998 Nov 25; 190(1):1-11. PubMed ID: 9826441
    [Abstract] [Full Text] [Related]

  • 17. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
    Alignani D, Maletto B, Liscovsky M, Rópolo A, Morón G, Pistoresi-Palencia MC.
    J Leukoc Biol; 2005 Jun 25; 77(6):898-905. PubMed ID: 15758079
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allergen-specific antibody and cytokine responses, mast cell reactivity and intestinal permeability upon oral challenge of sensitized and tolerized mice.
    Perrier C, Thierry AC, Mercenier A, Corthésy B.
    Clin Exp Allergy; 2010 Jan 25; 40(1):153-62. PubMed ID: 19689461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.